EpiCept 8-K 2012
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
2-29-12 Earnings Release
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Item 2.02 Results of Operations and Financial Condition.
On February 29, 2012, EpiCept Corporation (the "Registrant") issued a press release announcing its operating and financial results for the quarter and year ended December 31, 2011. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K.
Item 9.01 Financial Statements and Exhibits.
99.1 Press release of EpiCept Corporation, dated February 29, 2012, announcing the operating and financial results for the quarter and year ended December 31, 2011.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.